Retatrutide Side Effects vs Semaglutide: Comparison
Comparing retatrutide and semaglutide side effects reveals a surprising finding: despite activating three receptors instead of one, retatrutide does not appear to be significantly harder to tolerate. In fact, retatrutide's nausea rate (26%) was notably lower than semaglutide's (~44% in STEP trials), and overall discontinuation rates were comparable (Jastreboff et al., NEJM 2023; Wilding et al., NEJM 2021). The addition of GIP and glucagon receptors may actually moderate the pure GLP-1 GI side effects.
Medical Disclaimer: This article is for informational purposes only. Retatrutide is investigational. Cross-trial comparisons have inherent limitations. Always consult a qualified healthcare provider.
Side Effect Comparison Table
| Side Effect | Retatrutide 12mg | Semaglutide 2.4mg |
|---|---|---|
| Nausea | 26% | ~44% |
| Diarrhea | 22% | ~30% |
| Vomiting | 13% | ~24% |
| Constipation | 14% | ~24% |
| Dysesthesia | 20.9% | Not reported |
| Heart rate increase | 2-4 bpm | 1-3 bpm |
| Discontinuation rate | ~6% | ~7% |
Retatrutide: Jastreboff et al., NEJM 2023. Semaglutide: STEP trials.
Why Retatrutide May Be Easier on the GI Tract
The addition of GIP and glucagon receptors may modulate the GI effects of pure GLP-1 agonism. GIP receptor activation has been shown to have anti-emetic (anti-nausea) properties in some studies, which may partially counteract GLP-1-driven nausea. The result: a drug that produces 60% more weight loss than semaglutide with lower GI side effect rates.
Retatrutide's Unique Side Effects
The trade-off for lower GI side effects is the addition of glucagon-specific effects: dysesthesia (20.9% at 12mg), slightly greater heart rate increase, and potential liver enzyme elevation. These are generally mild and transient, but they represent a different side effect profile that patients switching from semaglutide should expect.
Treatment Options
Trimi offers compounded semaglutide at $99/month and compounded tirzepatide at $125/month. If semaglutide side effects are problematic, tirzepatide may be better tolerated (and more effective). Get started with Trimi.
Frequently Asked Questions
Does retatrutide cause more nausea than semaglutide?
No. Phase 2 data shows lower nausea rates for retatrutide (26%) compared to semaglutide (~44%). However, direct head-to-head data is needed for definitive comparison.
If I couldn't tolerate semaglutide, will I tolerate retatrutide?
Possibly better. The different receptor balance may produce fewer GI side effects. However, dysesthesia from the glucagon component would be a new consideration. Discuss with your provider.
Which drug has the lowest discontinuation rate?
Retatrutide and semaglutide have comparable discontinuation rates (~6-7%). Despite different side effect profiles, overall tolerability is similar.
Should I switch from semaglutide to tirzepatide for fewer side effects?
Many patients report better GI tolerance with tirzepatide compared to semaglutide. Trimi offers compounded tirzepatide at $125/month if you want to explore this option.
More on Retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).